FAS

Unqork Announces New Leadership Hire Sonny Hashmi in Commitment to Public Sector

Retrieved on: 
Wednesday, January 3, 2024
FedRAMP, Government, Architecture, General Services Administration, Public, Health, GSA, Federation, Insurance, Cloud computing, FAS, Public sector, Management

NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Unqork, the leading codeless platform, today announced that Sonny Hashmi has joined its leadership team as part of its strategic commitment to support government agencies. Hashmi will join Unqork as its Head of Public Sector, previously serving as the commissioner of the U.S. General Services Administration (GSA) Federal Acquisition Service (FAS) where he oversaw the delivery of over $100 billion in products and services to federal agencies.

Key Points: 
  • Former U.S. GSA Executive Sonny Hashmi Takes Helm as Unqork's Head of Public Sector, Leading Digital Transformation for Mission-Critical Initiatives
    NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Unqork , the leading codeless platform, today announced that Sonny Hashmi has joined its leadership team as part of its strategic commitment to support government agencies.
  • Hashmi will join Unqork as its Head of Public Sector, previously serving as the commissioner of the U.S. General Services Administration (GSA) Federal Acquisition Service (FAS) where he oversaw the delivery of over $100 billion in products and services to federal agencies.
  • Hashmi brings a deep understanding of the business challenges facing federal agencies and the role emerging technologies play in today's government landscape.
  • "At Unqork, we are dedicated to hiring talent that understands the needs and challenges of our customers inside and out," said Gary Hoberman, CEO and Founder, Unqork.

Pharming Group announces development plans for leniolisib for additional primary immunodeficiencies (PIDs)

Retrieved on: 
Wednesday, December 13, 2023
APDS, Food, FRCPA, Infection, NIAID, IND, Epidemiology, FDA, Prevalence, Immunodeficiency, Autoimmune lymphoproliferative syndrome, CTLA4, Pharmacokinetics, Primary immunodeficiency, Euronext Amsterdam, Protocol, Lymphocyte, PTEN, Gene, Bangladesh Technical Education Board, Face, NIH, Patient, Safety, FAS, PID, Pharmaceutical industry

Leiden, The Netherlands, December 13, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today the expansion of its rare disease pipeline with plans to develop leniolisib for additional primary immunodeficiencies (PIDs) beyond activated phosphoinositide 3-kinase delta syndrome (APDS).

Key Points: 
  • Leiden, The Netherlands, December 13, 2023: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces today the expansion of its rare disease pipeline with plans to develop leniolisib for additional primary immunodeficiencies (PIDs) beyond activated phosphoinositide 3-kinase delta syndrome (APDS).
  • Pharming has engaged with the US Food and Drug Administration (FDA) and has received feedback on its plans to develop leniolisib for PID disorders with immune dysregulation.
  • The Phase 2 clinical trial will evaluate leniolisib in PIDs with immune dysregulation linked to PI3Kẟ signaling in lymphocytes, with similar clinical phenotypes to APDS.
  • Building upon the success of leniolisib for APDS, we believe that leniolisib will continue to have efficient uses in rebalancing immune dysregulation in PIDs.

Venafi Surges Ahead with Strategic Product Innovations, Unprecedented 164% Year-Over-Year Growth in Global SaaS Business and Key Executive Appointment in 2023

Retrieved on: 
Tuesday, December 19, 2023
Software, Technology, Security, Cloud, Documentation, IBM, Partnership, Running, OpenShift, Workload, Cisco, Research, Software as a service, PKI, Somatosensory system, Automation, HQ, Heart, Headache, Red Hat, HashiCorp, Collection, Machine learning, Growth, Organization, VMware, IBM Z, FAS, BMC, Environment, Video game

Venafi , the inventor of machine identity management, today announced a staggering 164% year-over-year growth in its global Software as a Service (SaaS) business.

Key Points: 
  • Venafi , the inventor of machine identity management, today announced a staggering 164% year-over-year growth in its global Software as a Service (SaaS) business.
  • This phenomenal growth underscores Venafi's mission to future-proof leading organizations by delivering cutting-edge SaaS solutions that secure the heart of their digital infrastructure: machine identities.
  • Venafi’s strong year is also highlighted by a key appointment to its executive team, enhanced product offerings and more.
  • These innovations expand the potential for customers to solve more problems faster on the Venafi Control Plane .

Vanguard Announces Senior Leadership Change

Retrieved on: 
Tuesday, December 19, 2023
Personal, Broker-dealer, Philosophy, Economics, Research, Retirement, ETF, Education, Investment management, Dartmouth College, Investment, FAS, Financial adviser

VALLEY FORGE, Pa., Dec. 19, 2023 /PRNewswire/ -- Vanguard today announced the retirement of Tom Rampulla, managing director and head of Vanguard's Financial Advisor Services (FAS) division, following 35 years of dedicated service to the firm. Amma Boateng, current head of the Broker-Dealer channel within FAS, will join Vanguard's senior leadership team and become the head of the division effective January 1, 2024.

Key Points: 
  • Amma Boateng, current head of the Broker-Dealer channel within FAS, will join Vanguard's senior leadership team and become the head of the division effective January 1, 2024.
  • Mr. Rampulla joined Vanguard in 1988 and was appointed to Vanguard's senior leadership team as head of FAS in 2015.
  • Under his leadership, FAS has grown to manage more than $3 trillion in assets, serving more than 150,000 financial advisors with investments, services, education, and research.
  • "For more than 35 years, Tom has worked tirelessly for Vanguard clients and crew," said Vanguard Chairman and CEO Tim Buckley.

Planet Reports Financial Results for Third Quarter of Fiscal 2024

Retrieved on: 
Thursday, December 7, 2023
Technology, Satellite, Photography, Aerospace, Professional Services, Manufacturing, Software, Data Analytics, Data Management, Sentinel, Carbon, Risk management, Flood, PBC, Investment, Depreciation, Growth, IGAC, Webcast, SkySat, Civil Government, GIS, EBITDA, Instituto de Economia Agrícola, Defense, GAAP, NGIS, Table, Education, ACV, Intelligence, NYSE, Wildfire, USDA, FAS, Capital expenditure, EOP, GEO, API, BASF, Risk, Foreign Agricultural Service, Professional corporation, Rare-earth element, Bank, Film industry, Communications satellite, Planet, Pelican

Third quarter gross margin was 47%, compared to 50% in the third quarter of fiscal year 2023.

Key Points: 
  • Third quarter gross margin was 47%, compared to 50% in the third quarter of fiscal year 2023.
  • Third quarter Non-GAAP Gross Margin(1) was 52%, compared to 54% in the third quarter of fiscal year 2023.
  • (1) Please see “Planet’s Use of Non-GAAP Financial Measures” below for a discussion on how Planet calculates the non-GAAP financial measures presented herein.
  • The actual amount of these expenses during the fourth quarter of fiscal year 2024 and fiscal year 2024 will have a significant impact on Planet’s future GAAP financial results.

SecureAuth Arculix Delivers Tailored Digital User Journeys with its Powerful Orchestration Engine

Retrieved on: 
Wednesday, November 15, 2023
Data Management, Security, Technology, Software, Networks, Artificial Intelligence, Internet, Identity, MFA, Research, Organization, FAS, Risk, ADC, Rodan + Fields, Azure, Entra, VDI, Frustration, Microsoft, Video game, Online shopping, Citrix Systems

Arculix addresses today’s authentication and access management challenges by combining orchestration, leading-edge passwordless technology , and continuous authentication.

Key Points: 
  • Arculix addresses today’s authentication and access management challenges by combining orchestration, leading-edge passwordless technology , and continuous authentication.
  • The new version ensures risk is continually managed along an organization’s digital user journey through advanced orchestration and out-of-the-box integrations with Microsoft and Citrix.
  • Arculix’s enhanced Orchestration Engine streamlines the integration and deployment of identity services through a no-code experience, making it easier to design digital user journeys across multiple applications and heterogeneous environments.
  • “Arculix will enable customers to quickly integrate with various apps and streamline their processes to ensure risk is continually managed along their digital user journey.”
    To learn more about the latest release of Arculix by SecureAuth, please click here .

Resolution Economics Strengthens its Financial Advisory Services Practice with Addition of The Red Maple Group

Retrieved on: 
Monday, December 4, 2023
Research, FAS, Fraud, RMG, University, Growth, Economics

LOS ANGELES, Dec. 4, 2023 /PRNewswire/ -- Resolution Economics, LLC ("Resolution Economics" or "ResEcon") announced today that The Red Maple Group ("RMG"), an economic and forensic consulting firm has joined ResEcon as part of the Financial Advisory Services ("FAS") practice group.

Key Points: 
  • LOS ANGELES, Dec. 4, 2023 /PRNewswire/ -- Resolution Economics, LLC ("Resolution Economics" or "ResEcon") announced today that The Red Maple Group ("RMG"), an economic and forensic consulting firm has joined ResEcon as part of the Financial Advisory Services ("FAS") practice group.
  • They will bring further expertise in business valuations and Chief Financial Officer ("CFO") consulting to the FAS practice group.
  • Now in its 26th year, Resolution Economics is a leading specialty consulting firm providing economic and statistical analysis and regulatory compliance advice to companies, law firms, universities, and others.
  • "We are delighted to join Resolution Economics, a firm we have admired for many years," said Dr. Young.

Brii Bio Presents New Data Highlighting Progress Towards Achieving HBV Functional Cure at AASLD's The Liver Meeting® 2023

Retrieved on: 
Monday, November 13, 2023
Hepatology, Grade 2, FAS, Plasma, AASLD, Biotechnology, Vaccination, Patient, HBV, EOT, Enzyme inhibitor, Week, Liver, Health, Liver cancer, CHB, MD, Trial of the century, PPS, Seroconversion, Hepatitis, Pharmaceutical industry, Vaccine, HBsAg, Boston

DURHAM, N.C. and BEIJING, Nov. 13, 2023 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need, today shared three posters at the American Association for the Study of Liver Diseases (AASLD) The Liver Meeting® in Boston, MA, two of which were accepted as late-breakers providing new data from two Phase 2 assets, BRII-179 (VBI-2601) and BRII-835 (VIR-2218), within the chronic hepatitis B (CHB) clinical program.

Key Points: 
  • "We are pleased to share these data at The Liver Meeting that demonstrate the versatility of our HBV portfolio and critical insight in our search for a cure for HBV," said David Margolis, MD, Chief Medical Officer of Brii Bio.
  • "The important connection between HBsAg loss and antibody response provides a clear direction in further improving the functional cure rate and identifying patients who will most likely respond to curative treatments.
  • Highlights include:
    The PK characteristics of BRII-835 in patients with chronic HBV infection are generally similar to those in healthy volunteers.
  • In addition, Vir Biotechnology, Inc. ("Vir") is also investigating VIR-2218 and/or VIR-3434 for the treatment of HBV/HDV co-infection.

EQS-News: Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024

Retrieved on: 
Sunday, December 10, 2023
Management, Human resources, Supervisory board, Risk management, Information technology, FAS, Communication, CFO, West Coast of Vancouver Island Aquatic Management Board, IPO, ESG, Pension fund

Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024

Key Points: 
  • Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024
    The issuer is solely responsible for the content of this announcement.
  • Alzchem Group AG expands Management Board: Supervisory Board appoints Andreas Lösler as new CFO with effect from 1 January 2024
    Trostberg, December 8, 2023 – Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, is expanding its Management Board team.
  • At its meeting on 5 December 2023, the Supervisory Board unanimously resolved to appoint Andreas Lösler as the new CFO with effect from 1 January 2024.
  • Markus Zöllner, Chairman of the Supervisory Board of Alzchem Group AG: “Andreas Lösler is a proven financial expert from whose comprehensive expertise Alzchem will benefit greatly.

HII Reports Third Quarter 2023 Results

Retrieved on: 
Thursday, November 2, 2023
NYSE, Tax, HII, NEWS, SSBN, Ingalls Shipbuilding, Judgement, Growth, Columbia, FAS, Video game, Coal

Record third quarter revenues of $2.8 billion, up 7.2% compared to third quarter 2022

Key Points: 
  • Record third quarter revenues of $2.8 billion, up 7.2% compared to third quarter 2022
    New contract awards of $5.4 billion, resulting in backlog of approximately $49 billion
    NEWPORT NEWS, Va., Nov. 02, 2023 (GLOBE NEWSWIRE) -- HII (NYSE:HII) reported third quarter 2023 revenues of $2.8 billion, up 7.2% from the third quarter of 2022, driven primarily by growth at its Mission Technologies and Ingalls Shipbuilding segments.
  • Operating income in the third quarter of 2023 was $172 million and operating margin was 6.1%, compared to $131 million and 5.0%, respectively, in the third quarter of 2022.
  • Segment operating income1 in the third quarter of 2023 was $187 million and segment operating margin1 was 6.6%, compared to $166 million and 6.3%, respectively, in the third quarter of 2022.
  • New contract awards in the third quarter of 2023 were $5.4 billion, bringing total backlog to approximately $49 billion as of September 30, 2023.